CAS: Where Science and Strategy Converge

More Blog Articles

Pyschedelics for treating PTSD - blog hero image

November 18, 2021

Are psychedelics next to treat depression and PTSD?

Recent clinical trials show that psychedelics like LSD, MDMA, and Psilocybin - when properly controlled for dosing and administration - are having positive outcomes in treating mental health disorders. Read about the latest research.

Gain a competitive edge with IP Insights from CAS

November 16, 2021

Find the competitive edge in research and development with IP insights

Learn how incorporating an intellectual property (IP) strategy in research and development plans can give your business a competitive edge.

Neural network artificial intelligence

November 3, 2021

Assessing structural novelty of the first AI-designed drug candidates to go into human clinical trials

This blog details the recently published CAS indicator of drug innovation based on the structural novelty of new molecular entities (NMEs) which may better assess innovativeness of new drugs.

Subscribe to CAS Blog

Your privacy is important to CAS. More detail about how we use your information is in our privacy policy.